Mycos Research

Mycos Research is a biotechnology company specializing in the development of diagnostic and therapeutic solutions for fungal infections, with a primary focus on Pneumocystis pneumonia (PCP). Based in Loveland, Colorado, the company leverages its expertise in fungal biology to create sensitive diagnostic assays, including ELISA and PCR-based platforms, for the detection of Pneumocystis jirovecii. Beyond diagnostics, Mycos Research is actively involved in the research and development of monoclonal antibody-based therapies designed to prevent and treat PCP in immunocompromised patients. The company's R&D efforts have been significantly supported by Small Business Innovation Research (SBIR) grants from the National Institutes of Health (NIH). Mycos Research provides specialized reagents and expertise to the broader scientific community to advance the understanding of fungal pathogens. Their work addresses a critical need in infectious disease management for patients with HIV/AIDS, cancer, or those undergoing organ transplantation.